Subsidiary proposes Rs 10 crore buyback of 20.28 lakh shares

Corporate Actions View source PDF Explain this filing

HEALTHX · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+4.2%Reaction day

₹312.00

prior close

₹307.00

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used-0.7%+4.9% vs market

Healthcare Service Provider peers, median of 22sector+0.9%+3.3% vs sector

On the reaction day the stock moved 4.9 pts more than Nifty Microcap 250 and 3.3 pts more than its Healthcare Service Provider peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+3.4

10m

+3.7

15m

+4.2

30m

+6.2

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+4.2-0.7+4.9+0.9+3.3

Next day

+2.2-1.0+3.3-0.2+2.4

+2.1-1.4+3.5-0.1+2.2

+0.0-2.4+2.4-0.9+0.9

+1.0-4.5+5.5-3.2+4.1

+1.0-5.3+6.3-3.2+4.2

-1.2-4.3+3.2-4.4+3.2

15d

+1.3-4.6+5.9-6.6+7.8

-2.6-2.2-0.4-5.1+2.5

+2.2-5.6+7.8-8.5+10.7

-3.5-6.6+3.2-16.5+13.0

UpDownMarket · Nifty Microcap 250Sector · Healthcare Service Provider peers, median of 22Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Sastasundar Ventures said its material subsidiary Sastasundar Healthbuddy approved buying back 20,27,534 fully paid shares of Rs 10 each at Rs 493.21 per share, for up to Rs 10 crore. The plan requires shareholder approval. Trading in Sastasundar Ventures securities is closed for designated persons and relatives until 23 September 2025.

Likely market impact

The subsidiary buyback may improve group value, but it does not directly reduce the listed parent’s share count and still needs approval.